Click Therapeutics Acquires Assets of Better Therapeutics, Inc.
May 22, 2024
Click Therapeutics has acquired the assets of Better Therapeutics, Inc., including the FDA-authorized digital therapeutic AspyreRx (BT-001) and development candidates BT-002, BT-003 and BT-004. Click will integrate Better’s intellectual property into its AI-enabled platform to accelerate development of obesity and cardiometabolic digital therapeutics, optimizing programs for use alongside anti-obesity and diabetes medications.
- Buyers
- Click Therapeutics, Inc.
- Targets
- Better Therapeutics, Inc.
- Sellers
- Better Therapeutics, Inc.
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Mountain Crest Acquisition Corp II Completes Business Combination with Better Therapeutics
October 29, 2021
Healthcare Services
Mountain Crest Acquisition Corp II completed a business combination with Better Therapeutics, taking the prescription digital therapeutics company public on Nasdaq under the ticker BTTX. The transaction generated approximately $70 million in gross proceeds (including a PIPE led by Farallon Capital Management, RS Investments, Sectoral Asset Management and Monashee Investment Management) and included a contingent credit facility from Hercules Capital to fund clinical development and regulatory efforts for Better Therapeutics' lead product, BT-001.
-
Better Choice Company to Acquire SRx Health Solutions for Approximately $125 Million
September 3, 2024
Healthcare Services
Better Choice Company Inc. (NYSE American: BTTR) signed a definitive all-stock agreement to acquire SRx Health Solutions Inc. for approximately $125 million. The deal would combine Better Choice's pet health business (Halo) with SRx's Canadian specialty pharmacy network, creating a broader health and wellness company and unlocking operational synergies and geographic/vertical expansion.
-
Catalent Acquires Bettera Brands from Highlander Partners for $1 Billion
August 30, 2021
Food & Beverage
Catalent, Inc. agreed to acquire Bettera Holdings, LLC (Bettera Brands) from Highlander Partners for $1 billion. The acquisition expands Catalent's consumer health and nutraceutical manufacturing capabilities—adding Bettera's gummy, soft chew, and lozenge production capacity and approximately 500 employees across four U.S. facilities.
-
Better Choice Company Acquires Aimia Pet Healthco
February 9, 2024
Veterinary
Better Choice Company (NYSE: BTTR) has acquired all issued and outstanding common shares of Aimia Pet Healthco Inc. The acquisition gives Better Choice in-house control of Aimia's GLP-1 related R&D and enables the company to manage clinical trials and develop weight-loss supplements/treatments for pets under its Halo brand.
-
PointClickCare Acquires American HealthTech from CPSI
January 17, 2024
Healthcare Services
PointClickCare Technologies has acquired American HealthTech, Inc. (AHT), a subsidiary of Computer Programs and Systems, Inc. (CPSI), in a divestiture intended to transition AHT customers to PointClickCare's post-acute care platform. CPSI divested AHT as part of a business transformation and selected PointClickCare to continue supporting AHT's post-acute EHR customers and integrate them into its broader care-collaboration network.
-
Cycle Pharmaceuticals (Cycle Group) Acquires Applied Therapeutics, Inc.
February 3, 2026
Pharmaceuticals
Cycle Group Holdings Limited (Cycle Pharmaceuticals) has completed the acquisition of NASDAQ-listed Applied Therapeutics, a clinical-stage biopharmaceutical company focused on novel CNS-penetrant therapies for rare metabolic diseases. The transaction was funded from Cycle's cash on hand and brings Applied's lead candidate govorestat and rare-disease pipeline into Cycle's rare metabolic disease platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.